Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 1;22(9):56.
doi: 10.1007/s11926-020-00933-4.

The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis

Affiliations
Review

The Impact of Obesity on Disease Activity and Treatment Response in Rheumatoid Arthritis

Dilli Poudel et al. Curr Rheumatol Rep. .

Abstract

Purpose of the review: A growing number of studies have suggested that disease outcomes and response to therapy may be different in patients with rheumatoid arthritis (RA) who are obese. The goal of this review is to examine the most recent literature, with a focus on the impact of obesity on the assessment of disease activity and treatment outcomes in RA.

Recent findings: Obesity is common in patients with RA and can have a substantial impact on patient symptoms and outcomes. Obesity is associated with higher rates of chronic pain and opiate use, elevated inflammatory markers, and less reliable physical exam findings, making assessment of disease activity and treatment response more challenging. Despite seemingly worse clinical disease activity, evidence has accumulated demonstrating that obese patients with RA have less inflammation by imaging and lower rates of radiographic progression over time. Whether obesity influences the effectiveness of specific therapies remains controversial. Obesity is very common and is associated with more severe symptoms and higher rates of disability among RA patients. While clinical disease activity is frequently observed to be higher in obese patients with RA, it remains unclear whether poorer treatment response rates in this setting are related to reduced efficacy of therapies or are an artifact of biases in the accurate assessment of the disease.

Keywords: Adiposity; Body mass index; Obesity; Rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Conceptual model of the ways in which obesity can affect aspects of RA clinical manifestations and disease activity
Fig. 2
Fig. 2
Trim and fill plot demonstrating that there is evidence of publication bias in meta-analyses of studies evaluating the effects of obesity on response to therapy in RA

References

    1. George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, et al. Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res. 2017;69(12):1789–98. 10.1002/acr.23229 - DOI - PMC - PubMed
    2. This article demonstrates how excess adiposity is associated with elevation in systemic cytokines, C-Reactive Protein (CRP), and Erythrocyte Sedimentation Rate (ESR) and impacts disease activity assessment.

    1. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131–5. - PubMed
    1. Maglio C, Peltonen M, Rudin A, Carlsson LMS. Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the Swedish Obese Subjects Study. Obesity (Silver Spring). 2017;25(12):2068–73. 10.1002/oby.21955 - DOI - PMC - PubMed
    2. This study demonstrates a strong relationship between metabolic obesity, psoriasis, and psoriatic arthritis, and negative effect of surgical weight reduction on incidence of psoriasis in a long term cohort study.

    1. Maglio C, Zhang Y, Peltonen M, Andersson-Assarsson J, Svensson PA, Herder C, et al. Bariatric surgery and the incidence of rheumatoid arthritis - a Swedish Obese Subjects study. Rheumatology (Oxford). 2020;59(2):303–9. 10.1093/rheumatology/kez275. - DOI - PMC - PubMed
    1. Relieving Pain in America: a blueprint for transforming prevention, care, education, and research. Mil Med. 2016;181(5):397–9. doi: 10.7205/MILMED-D-16-00012. - DOI - PubMed

Publication types